(Reuters) - European stocks eased from eight-month highs as tighter coronavirus-driven restrictions across the continent hit travel stocks, halting a broader rally that was powered by encouraging COVID-19 vaccine news.
The pan-European STOXX 600 (STOXX) slipped 0.1% in morning trading. The index closed at it highest level since Feb. 27 on Monday after positive data from drugmaker Moderna 's (O:MRNA) COVID-19 vaccine.
Earlier, Pfizer (NYSE:PFE) and partner BioNTech flagged strong progress in their COVID-19 vaccine, sparking a rally in global equities last week.
"Though the vaccine developments were incredibly positive, markets still have a bit of a 'show me the logistics' side to it," Deutsche Bank (DE:DBKGn) strategist Jim Reid wrote in a morning note.
Near-term economic outlook remains hazy as the grip of the virus grows stronger, with Sweden moving to restrict the size of public gatherings and a British medical adviser suggesting strengthening the three-tier system of restrictions when the full lockdown in England ends.
Travel stocks (SXTP) fell the most, with British airline EasyJet (L:EZJ) sliding 5% after it recorded a 1.27 billion pound ($1.68 billion) annual loss, the first in its history that also highlights the extent of the pandemic's impact on air travel.
European banks (SX7P) retreated after a more than 3% surge on Monday. BBVA (MC:BBVA) fell 4.2% after it and smaller rival Sabadell (MC:SABE) said they were in talks to create Spain's second-biggest domestic lender by assets.
Sabadell shares jumped 3.5% to become the second-biggest gainer on the STOXX 600.
Other economically sensitive sectors such as oil and gas (SXEP) and automakers (SXAP) retreated after a sharp rally in the past week as hopes of a vaccine prompted investors to bet on a faster economic recovery.
Tobacco company Imperial Brands (L:IMB) gained 3% after it forecast a rise in profit for 2021, helped by expected improvements in its e-cigarette business.
Defensive sectors such as utilities (SX6P) and healthcare (SXDP) inched higher.